HMS
EGRX

Hanseatic Management Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Hanseatic Management Services’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8
Closed -$1K – 472
2017
Q1 		$1K Hold
8
– – ﹤0.01% 376
2016
Q4 		$1K Buy
+8
New +$581 ﹤0.01% 293
2016
Q2 		– Sell
-18
Closed -$1K – 355
2016
Q1 		$1K Hold
18
– – ﹤0.01% 225
2015
Q4 		$2K Hold
18
– – ﹤0.01% 271
2015
Q3 		$1K Buy
+18
New +$1.5K ﹤0.01% 338

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Hanseatic Management Services's EGRX Position: Q2 2017 in Review

Hanseatic Management Services sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2017, closing a stake of 8 shares — an estimated $1K sold.

Hanseatic Management Services first reported a position in EGRX in Q3 2015 and held it in 5 quarters. The position peaked at $2K in Q4 2015. 175 funds tracked by Wall St. Rank hold EGRX as of Q2 2017.

  • Hanseatic Management Services reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Hanseatic Management Services sold 8 Eagle Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1K.
  • Hanseatic Management Services first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
  • Hanseatic Management Services's Eagle Pharmaceuticals, Inc. position peaked at $2K in Q4 2015.
  • 175 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2017.

Based on Hanseatic Management Services's 13F filing for Q2 2017, filed 11 Aug 2017.